Insiders Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
70.57 ^USD	+0.28%		-2.62%	-1.19%

Apr. 08	Ligand Pharmaceuticals Incorporated Announces New Topiram Injection Data Presented At 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference	CI
Apr. 03	Ligand Pharmaceuticals Appoints Scott Plesha to the Role of Chief Executive Officer	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ligand Pharmaceuticals Appoints Scott Plesha to the Role of Chief Executive Officer	Apr. 03	CI
Ligand Pharmaceuticals Incorporated Announces Management Appointments	Feb. 16	CI
Ligand Pharmaceuticals Incorporated Appoints Martine Zimmermann to its Board of Directors	23-09-26	CI
Insider Sell: Ligand Pharmaceuticals	23-05-18	MT
Insider Sell: Ligand Pharmaceuticals	23-05-12	MT
Ligand Pharmaceuticals Names Todd Davis Chief Executive	22-12-05	MT
Ligand Pharmaceuticals Incorporated Announces the Resignation of John Higgins as Director, Effective December 31, 2022	22-12-05	CI
Ligand Pharmaceuticals Incorporated Announces CEO Changes	22-12-05	CI
Insider Sell: Ligand Pharmaceuticals	22-11-10	MT
Ligand Pharmaceuticals Incorporated Appoints Octavio Espinoza as Chief Financial Officer	22-11-01	CI
Ligand Pharmaceuticals Incorporated Announces Management Changes	22-11-01	CI
Ligand Pharmaceuticals Incorporated Appoints Jason Haas to its Board of Directors	22-06-29	CI
Ligand Pharmaceuticals Incorporated and Avista Public Acquisition Corp. II Announces Executive Changes	22-03-23	CI
Insider Sell: Ligand Pharmaceuticals	21-11-17	MT
Ligand Pharmaceuticals Incorporated Appoints Dr. Jennifer Cochran to its Board of Directors	21-07-14	CI
Insider Trends: Insider at Ligand Pharmaceuticals Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	21-02-09	MT
Ligand Pharmaceuticals Incorporated Appoints Sarah Boyce to the Company's Board of Directors	19-10-15	CI
Ligand Pharmaceuticals Incorporated Announces Executive Changes	18-01-29	CI
Ligand Pharmaceuticals Incorporated Appoints Nancy Ryan Gray as Board of Director	17-08-21	CI
Christel Iffland Joins Ligand as Vice President, Antibody Technologies	17-02-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Insiders

Filters